Speciality Medicines
add_icon

Speciality Medicines

188.00
+15.85
(9.21%)
Market Cap
165.23 Cr
PE Ratio
-
Volume
19,000.00
Day High - Low
188.00 - 169.10
52W High-Low
381.20 - 121.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
165.23 Cr
EPS
14.90
PE Ratio
-
PB Ratio
-
Book Value
81.03
EBITDA
14.50
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
18.31
Debt to Equity
0.17
Forecast For
Actual

Company News

View All News
Caret
neutral
Speciality Medicines Ltd closes insider trading window from Oct 1, 2026, until 48 hours after Q2FY27 results declaration.
neutral
Speciality Medicines Limited concluded its 5th AGM on September 28, 2026, with all resolutions passed unanimously. Key approvals included the adoption of FY26 financial statements and the re-appointment of Sumit Goyani.
neutral
Speciality Medicines Ltd board approved the draft directors' report for FY26 and called its 5th AGM for September 28, 2026. The meeting was held on September 3, 2026.
View more
Growth Rate
Revenue Growth
30.09 %
Net Income Growth
80.56 %
Cash Flow Change
80.09 %
ROE
-22.09 %
ROCE
-31.56 %
EBITDA Margin (Avg.)
19.20 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
2026
TTM
Revenue
40
23
28
59
76
0
Expenses
38
20
22
49
62
0
EBITDA
2
4
5
9
15
0
Operating Profit %
6 %
15 %
19 %
16 %
18 %
0 %
Depreciation
0
0
0
0
0
0
Interest
0
0
1
1
1
0
Profit Before Tax
2
3
5
9
13
0
Tax
1
1
2
2
0
0
Net Profit
2
2
3
7
13
0
EPS in ₹
4.87
4.72
7.07
11.18
14.90
0.00

Order Value Trend

FY 2026-27 order value₹32.80 Cr
QoQ growth-99.99%
FY 2026-272 Orders
International entity
100.00%

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
6
13
23
40
95
Fixed Assets
2
2
2
2
2
Current Assets
4
11
21
36
89
Capital Work in Progress
0
0
0
0
0
Investments
0
0
0
0
0
Other Assets
4
12
21
38
93
Total Equity & Liabilities
6
13
23
40
95
Current Liabilities
4
6
7
7
19
Non Current Liabilities
0
1
1
3
5
Total Equity
2
6
15
31
71
Reserve & Surplus
2
2
10
24
62
Share Capital
0
4
5
6
9

Cash Flow

Cash Flow
2022
2023
2024
2025
2026
Net Cash Flow
0
0
0
1
24
Investing Activities
-2
0
0
-1
-3
Operating Activities
1
-4
-5
-6
-1
Financing Activities
2
4
5
9
28

Share Holding

% Holding
Aug 2024
Sept 2025
Mar 2026
Promoter
62.70 %
62.39 %
43.43 %
FIIs
0.00 %
0.00 %
0.24 %
DIIs
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
48.57 %
Others
37.30 %
37.61 %
7.77 %
No of Share Holders
93
97
103

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2026 231.45 218.75
28 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2026 148.50 162.20

Announcements

Closure of Trading Window9 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report9 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM9 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2026
Reg. 34 (1) Annual Report.Sep 03, 2026
Notice Of 5Th Annual General MeetingSep 03, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On September 03 2026Sep 03, 2026
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 Regarding Approval For Two New Products In EthiopiaAug 12, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2026
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 Regarding Appointment Of Investor And Public Relations Agency Of The CompanyAug 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Results - Financial Results For The Half Year And Year Ended March 31 2026May 28, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E On May 28 2026May 28, 2026
Board Meeting Intimation for Meeting Of Board Of Directors Of Speciality Medicines Limited To Be Held On May 28 2026May 21, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011May 19, 2026
Intimation Of Contact Details Of Key Managerial Personnel Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 28, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 28, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On April 28 2026Apr 28, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 23, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 22, 2026
Reply To Clarification Sought On Price Movement By Stock ExchangeApr 20, 2026
Clarification sought from Speciality Medicines LtdApr 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2026
Closure of Trading WindowMar 31, 2026
Listing of Equity Shares of Speciality Medicines LtdMar 30, 2026

Technical Indicators

RSI(14)
Neutral
61.24
ATR(14)
Less Volatile
6.82
STOCH(9,6)
Neutral
71.55
STOCH RSI(14)
Neutral
71.56
MACD(12,26)
Bullish
2.06
ADX(14)
Weak Trend
15.17
UO
Bearish
71.23
ROC
Uptrend And Accelerating
11.10
WillR
Overbought
-3.33